ATA53477A - Verfahren zur herstellung von neuen clavulan- saeurethioaethern - Google Patents

Verfahren zur herstellung von neuen clavulan- saeurethioaethern

Info

Publication number
ATA53477A
ATA53477A AT53477A AT53477A ATA53477A AT A53477 A ATA53477 A AT A53477A AT 53477 A AT53477 A AT 53477A AT 53477 A AT53477 A AT 53477A AT A53477 A ATA53477 A AT A53477A
Authority
AT
Austria
Prior art keywords
ethioethers
new
production
clavulan
acid
Prior art date
Application number
AT53477A
Other languages
English (en)
Other versions
AT351675B (de
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3892/76A external-priority patent/GB1574906A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of ATA53477A publication Critical patent/ATA53477A/de
Application granted granted Critical
Publication of AT351675B publication Critical patent/AT351675B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
AT53477A 1976-01-31 1977-01-28 Verfahren zur herstellung von neuen clavulan- saeurethioaethern AT351675B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3892/76A GB1574906A (en) 1976-01-31 1976-01-31 Therapeutic compounds containing - lactams
GB1900276 1976-05-08

Publications (2)

Publication Number Publication Date
ATA53477A true ATA53477A (de) 1979-01-15
AT351675B AT351675B (de) 1979-08-10

Family

ID=26238678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT53477A AT351675B (de) 1976-01-31 1977-01-28 Verfahren zur herstellung von neuen clavulan- saeurethioaethern

Country Status (31)

Country Link
US (2) US4428958A (de)
JP (1) JPS5295689A (de)
AR (3) AR214306A1 (de)
AT (1) AT351675B (de)
AU (1) AU515736B2 (de)
BG (1) BG27751A3 (de)
CA (1) CA1089471A (de)
CH (2) CH637655A5 (de)
CS (1) CS196341B2 (de)
DD (1) DD128196A5 (de)
DE (1) DE2702954A1 (de)
DK (1) DK146940C (de)
ES (1) ES455404A1 (de)
FI (1) FI63581C (de)
FR (1) FR2339616A1 (de)
GR (1) GR62544B (de)
HK (1) HK69883A (de)
IE (1) IE44759B1 (de)
IL (1) IL51267A (de)
KE (1) KE3303A (de)
LU (1) LU76668A1 (de)
MX (1) MX4950E (de)
NL (1) NL7700892A (de)
NO (1) NO770279L (de)
NZ (1) NZ183117A (de)
PH (1) PH13924A (de)
PT (1) PT66071B (de)
RO (1) RO69712A (de)
SE (1) SE441359B (de)
SU (1) SU645583A3 (de)
YU (1) YU10777A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
GB2004541B (en) * 1977-09-16 1982-05-12 Beecham Group Ltd Ethers of clavulanic acid a process for their preparation and pharmaceutical compositions containing them
EP0008899B1 (de) * 1978-09-05 1982-09-15 Beecham Group Plc Clavulansäurederivate, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0018203B1 (de) * 1979-04-21 1983-03-02 Beecham Group Plc Clavulansäure-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
IL60056A0 (en) * 1979-05-17 1980-07-31 Beecham Group Ltd Clavulanic acid derivatives,their preparation and pharmaceutical compositions containing them
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039673A (en) 1973-10-30 1977-08-02 Bayer Aktiengesellschaft Penicillins and cephalosporins and their production
US3983113A (en) 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials

Also Published As

Publication number Publication date
US4505894A (en) 1985-03-19
ES455404A1 (es) 1978-05-01
CH637655A5 (de) 1983-08-15
SE441359B (sv) 1985-09-30
GR62544B (en) 1979-05-07
DK146940B (da) 1984-02-20
CS196341B2 (en) 1980-03-31
SE7700946L (sv) 1977-08-01
AU515736B2 (en) 1981-04-30
DD128196A5 (de) 1977-11-02
CH638529A5 (de) 1983-09-30
SU645583A3 (ru) 1979-01-30
NO770279L (no) 1977-08-02
IL51267A0 (en) 1977-03-31
AU2177077A (en) 1978-08-03
PT66071B (en) 1978-06-23
AT351675B (de) 1979-08-10
IE44759L (en) 1977-07-31
JPS613349B2 (de) 1986-01-31
KE3303A (en) 1983-08-05
FI770295A (de) 1977-08-01
CA1089471A (en) 1980-11-11
AR216555A1 (es) 1979-12-28
AR216925A1 (es) 1980-02-15
RO69712A (fr) 1980-07-15
AR214306A1 (es) 1979-05-31
DK146940C (da) 1984-07-30
YU10777A (en) 1982-06-30
FI63581C (fi) 1983-07-11
FR2339616A1 (fr) 1977-08-26
IE44759B1 (en) 1982-03-24
HK69883A (en) 1983-12-23
FR2339616B1 (de) 1980-04-11
IL51267A (en) 1979-12-30
NZ183117A (en) 1979-10-25
MX4950E (es) 1983-01-12
LU76668A1 (de) 1977-06-28
DK38577A (da) 1977-08-01
NL7700892A (nl) 1977-08-02
JPS5295689A (en) 1977-08-11
DE2702954A1 (de) 1977-08-04
PH13924A (en) 1980-11-04
US4428958A (en) 1984-01-31
BG27751A3 (en) 1979-12-12
PT66071A (en) 1977-02-01
FI63581B (fi) 1983-03-31

Similar Documents

Publication Publication Date Title
AT349000B (de) Verfahren zur herstellung von neuen trans-4- cyclohexan-1-carbonsaeureestern
AT348999B (de) Verfahren zur herstellung von neuen biphenylcarbonsaeureestern
ATA348877A (de) Verfahren zur herstellung von neuen n- acylierten
ATA283676A (de) Verfahren zur herstellung von neuen phenylalkancarbonsaure-derivaten
AT349634B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosiden
AT343810B (de) Verfahren zur herstellung von neuen fusidinsaurederivaten
AT352279B (de) Verfahren zur herstellung von neuen rifamyzin- verbindungen
AT351675B (de) Verfahren zur herstellung von neuen clavulan- saeurethioaethern
ATA303477A (de) Verfahren zur herstellung von neuen indazolyl- (4-)-oxy-propanolaminen
AT347457B (de) Verfahren zur herstellung von neuen indolinospiropyranverbindungen
AT353803B (de) Verfahren zur herstellung von neuen acylamino- sulfenyl-carbaminsaeurefluoriden
AT347963B (de) Verfahren zur herstellung von neuen 4- halogenazetidinon-1-essigsaeurederivaten
AT352280B (de) Verfahren zur herstellung von neuen rifamyzin- verbindungen
AT353411B (de) Verfahren zur herstellung von neuen 4- -dedimethylamino-4-arylsulfonamido-5a,6- -anhydrotetracyclinen
AT352743B (de) Verfahren zur herstellung von neuen hydroxim- saeureestern
AT358598B (de) Verfahren zur herstellung von neuen barbitur- saeurekomplexen
AT358189B (de) Verfahren zur herstellung von neuen aspidosper- midinen
ATA311378A (de) Verfahren zur herstellung von neuen halogen- arylmalonamidooxacephalosporinen
AT351558B (de) Verfahren zur herstellung von neuen 2-formyl- amino-phenylguanidinen
ATA326378A (de) Verfahren zur herstellung von neuen anthranil- saeureestern
AT356301B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT342555B (de) Verfahren zur herstellung von neuen 2-methyl-3-buten-3-halogen-2-olen
ATA961076A (de) Verfahren zur herstellung von neuen 5-methylisoxazol-3-carbonsauresalzen
ATA812178A (de) Verfahren zur herstellung von neuen 5-fluor- dihydrouracilen
ATA641278A (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties